Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis

• Váldodahkkit: Xirui Guo (Dahkki), Yao Xiao (Dahkki), Huan Liu (Dahkki), Qinchuan Li (Dahkki), Qian Jiang (Dahkki), Chun Liu (Dahkki), Fangqing Xie (Dahkki), Hongju Wang (Dahkki), Fang Yang (Dahkki), Xiao Han (Dahkki), Hengbo Yang (Dahkki), Yong Yang (Dahkki), Yongqin Ye (Dahkki), XiaoHong Gan (Dahkki), Enwu Long (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BackgroundSince 2009, a series of ambitious health system reforms have been launched in China, including the zero mark-up drug policy (ZMDP); the policy was intended to reduce substantial medicine expenses for patients by abolishing the 15% mark-up on drugs. This study aims to evaluate the impacts o...